Introduction
In 2006 the European Union passed a regulation which required registration of all commercial chemical substances (EC No. 1907 . This regulation known as REACH (Registration, Evaluation, Authorization and Restriction of Chemicals) required, among other things, that information on physical, toxicological and environmental hazards be compiled and systematically reviewed to assure that the potential hazards of the substances were well characterized. It was further required that the hazard information be used to calculate exposure levels at which no health risks are expected, Derived No Effect Levels (DNELs). These DNEL values are required for inhalation, oral and dermal routes of exposure and for both workers and the population at large. DNELs are then compared to the anticipated exposures associated with each intended use to determine whether potential risks exist, and, if so, to recommend risk management measures. If potential risks are identified, it is then necessary to recommend additional measures by which exposures can be lowered to appropriate levels.
Previously there had been efforts to compile and systematically review the available hazard information including the Existing Substances Risk Assessment initiative in Europe (European Commission, 1993 ) and the U.S. High Production Volume (HPV) Challenge Program under which chemical manufacturers agreed to provide health and safety information on the chemicals they produce (US EPA, 2000) . However, the REACH regulation went beyond these previous initiatives by not only encompassing hazard identification for human health, environmental effects and physical/chemical properties but additionally requiring formal risk assessments for all intended uses throughout the supply chain. The additional elements for human health protection introduced by the REACH regulation included the calculations of DNELs and "Risk Characterization Ratios (RCRs)", i.e., the ratios of the predicted exposures to the derived no effect levels, and the development of tools by which exposures could be estimated, RCRs calculated, required actions be defined, and, ultimately, the relevant information communicated to end users via safety data sheets (SDS).
All of these requirements were challenging, particularly so for substances of complex and variable composition, i.e., substances of unknown or variable composition, complex reaction products or biological materials, UVCBs. The objective of this paper is to describe the procedures used to develop the necessary information for one group of complex substances, hydrocarbon solvents, using a specific group of these solvents, commonly known as white spirit or mineral spirits, as an example. The solvents in this group are also challenging because their uses in many applications required numerous exposure risk assessments.
Background

General information on hydrocarbon solvents
Hydrocarbon solvents are substances comprised of only hydrogen and carbon and manufactured for use as solvents. This distinguishes them from petroleum fuels which are hydrocarbons but not intended for solvent uses and from other organic solvents which also contain atoms such as oxygen or chlorine. Although most hydrocarbon solvents are complex substances, 1 they may be among the least complicated of the UVCBs, in part because of technical specifications; more specifically, the compositional elements are constrained to a limited number of constituent types, i.e., normal paraffinic, isoparaffinic (branched), cycloparaffinic (cyclic, also known as naphthenic), and aromatic constituents in varying proportions and also because of limitations on boiling range by which carbon numbers are limited for most solvents, i.e., usually ≤ 3 carbon numbers for specific solvents with an overall carbon number range of approximately C5-C20 for hydrocarbon solvents as a group. Further, most of the constituents have similar toxicological properties, allowing the health hazards to be characterized on a generic basis. In fact, for most hydrocarbon solvents, the effects of toxicological concern; acute central nervous system (CNS) depression, ocular and upper respiratory irritation, and chemical pneumonitis, are more closely related to physical and chemical properties than to specific compositions (McKee et al., 2015) . Taking into account the physical and chemical properties and important compositional elements, hydrocarbon solvents were grouped into 9 generic categories (Table 1) based on compositional differences including aliphatic versus aromatic content, carbon number range, and levels of particularly hazardous constituents such as n-hexane or naphthalene.
2 Accordingly, substances within the various categories have similar compositions and physical/chemical properties, are manufactured by similar processes, and are intended for similar end uses. Although the categorization per se was not specifically intended for hazard evaluation, it is a good fit for this purpose. Since the substances have similar compositions and physical/chemical properties, and are converted to similar metabolites, it was hypothesized that they would also have similar toxicological properties such that data for representative hydrocarbon solvents could be used to characterize the hazards of the other solvents in the same category. This approach was used initially to compile data submitted in response to the OECD HPV initiative 3 and, later, during the REACH registration process, to assemble the information to address questions about data sufficiency and as a basis for DNEL derivation. As indicated above, the present document, describes how DNELs were calculated and exposure assessments were carried out using the category of substances (C9-C14 aliphatic [2-25% aromatic] hydrocarbon solvents) containing products commonly known as white spirit or mineral spirits as an example. This was chosen because it contains substances that are chemically complex (UVCB), including both aliphatic and aromatic components, and are used in a wide variety of applications, creating opportunities to address both toxicological and exposure issues. Further, these substances have been extensively investigated, so a large body of information is available. For purposes of REACH registration, the hydrocarbon solvents industry in Europe developed a "naming convention" (HSPA, 2011) . This nomenclature was an advancement over the Chemical Abstract Services (CAS) registry numbers which were introduced in the 1970s to allow hydrocarbon solvents and other complex petroleum-derived substances to be included in the registry of existing substances required by the Toxic Substances Control Act (TSCA) as well as the European Inventory (Table 1) .
2.2. Specific information on white spirit, mineral spirits and similar substances "White spirit" and "Mineral spirits" are terms that have been applied to complex hydrocarbon solvents with boiling ranges of approximately 140°C-220°C and containing approximately 20% aromatic constituents. 4 The first solvent of this type, "Stoddard solvent", a product developed for use in the dry-cleaning industry, was produced from crude petroleum by distillation, followed by desulfurization. It had a boiling range of approximately 150-200°C and contained 15%-25% aromatics (maximum 25%). Based on the distillation range, the aliphatic constituents were primarily C9-C11 alkanes and cycloalkanes, and the aromatic constituents were primarily C9 aromatics, i.e., isomers of trimethylbenzene and ethyltoluene. This type of solvent is now defined as a type 1, full-range mineral spirit with a boiling range of 149-213°C (ASTM, 1971) . The product specifications, set to meet technical requirements, permit some compositional variability, and, in fact, the compositions of commercial products have varied over the years, depending on the source of petroleum from which they were derived and the specific manufacturing processes utilized. In the 1960-1970 time frame, the development of air pollution regulations led to the development of complex aliphatic solvents with reduced aromatic content, and in the early 1980s, products with even lower (i.e., < 2%) aromatic content became commercially available. For REACH registration purposes, these solvents were separated into two categories, differentiated by aromatic content; those with < 2% aromatics were placed in category 8 and the remainder into category 3. Although most category 3 solvents now contain approximately 20% aromatics, solvents with lower aromatic content were available in the past in some locations and were used for some of the toxicology studies summarized below. On the assumption that the aromatic components were more likely to be more hazardous than the aliphatic components, reliance has been placed on studies with higher levels of aromatics to the extent possible. As noted above, for purposes of toxicological characterization a "grouping/category" approach was used, by which it was assumed that data on any member of the category could be used to characterize the hazards of all of the category members.
6 For this group of substances, there were several toxicological studies for most of the endpoints, providing evidence of similarity of response. When necessary and appropriate, data from studies of analogous substances were also used. These analogous substances included category 8 (low aromatic) solvents which are similar to the aliphatic contents of white spirit and category 1 (aromatic) solvents which are similar to the aromatic constituents. On the assumption that the aromatic constituents are more likely to be hazardous than the aliphatics, the data from aromatic solvents were assumed to be "worst case". Other analogous substances included jet fuels (JP-8, Jet-A) and hydrodesulfurized kerosene which are also complex petroleum-derived substances containing approximately 20% aromatic constituents but as these substances have wider distillation ranges and may contain higher levels of two-ring aromatic compounds than white spirit, they were also assumed to be "worst case".
Toxicokinetic properties of white spirit/mineral spirits
The constituents of C9-C14 aliphatic (2-25% aromatic) hydrocarbon solvents are relatively well absorbed if inhaled (Astrand et al., 1975) . If ingested, approximately 60-80% of the constituents are absorbed according to an empirical relationship developed by Albro and Fishbein (1970) . However, the constituents of these solvents are poorly absorbed following dermal contact. Based on studies with marker constituents (Baynes et al., 2000; Kim et al., 2006; Muhammad et al., 2005; Singh and Singh, 2003) , percutaneous absorption of the aliphatic and aromatic constituents of these solvents is low, and it is not anticipated that dermal contact would result in a substantial contribution to systemic dose under most circumstances (McDougal et al., 2000) . Except for one anomalous result with tridecane, the percutaneous absorption rates for aliphatic constituents ranging from C9-C14 (from nonane to tetradecane) are well below 1 μg/cm 2 /hr, and most of the percutaneous absorption values for the relevant aromatic constituents are < 2 μg/cm 2 /hr (Baynes et al., 2000; Singh and Singh, 2003; Muhammad et al., 2005; Kim et al., 2006) (Table 2 ). The only exceptional values are those for naphthalene which range from 4.2 to 6.6 μg/ cm 2 /hr (Muhammad et al., 2005) , but naphthalene levels are low in most of the solvents. After considering all of the information, it seemed reasonable to use 2 μg/cm 2 /hr as a relatively conservative percutaneous absorption value for all hydrocarbon solvent constituents including those in white spirit/mineral spirit. Once absorbed, the constituents of hydrocarbon solvents are preferentially distributed to the adipose tissues, liver, and central nervous system. As shown by Zahlsen et al. (1992 Zahlsen et al. ( , 1993 , concentrations of nalkanes, iso-alkanes and aromatics in adipose tissue, liver and brain increased with increasing carbon number over the range C6-C10. However, as noted by Hau et al. (2001) , uptake of aliphatic hydrocarbons with carbon numbers > C10 into the central nervous system appeared to be inhibited, and this was demonstrated empirically by the declines in blood/air ratios for n-alkanes with carbon numbers ranging from C10-C13 (Nilsen et al., 1988) and more directly for cycloparaffins (referred to as naphthenics in the original reference) for which there appeared to be a breakpoint at C9 (Zahlsen et al., 1992) .
As shown by Hissink et al. (2007) , at exposure levels in the range of 600 mg/m 3 (110 ppm), steady-state concentrations in the brain, estimated by pharmacokinetic modeling, are achieved relatively rapidly, but the levels also decline rapidly when exposure stops. Initial half-lives for hydrocarbon constituents in the brain are approximately 2 h, and, in studies in which humans were exposed to white spirit for 4 h at 570 mg/m 3 (104 ppm), levels of white spirit constituents in blood and expired air were below detection limits 8 h after the end of the exposure period. The pharmacokinetic models predicted that at equivalent external exposure levels, the concentrations of aliphatic hydrocarbons in the human central nervous system would be similar to those in rats, whereas concentrations of cycloaliphatic and aromatic constituents would be about twice as high in humans as in rats (Hissink et al., 2007 (Hissink et al., , 2009 . Thus, assuming similar acute CNS effects at similar hydrocarbon concentrations in the central nervous system, no effect levels in humans are predicted to be within approximately a factor of two of those measured in rodents, and this has been confirmed experimentally. As 4 White spirit" is sometimes used in a broader and more generic sense in academic publications and in some regulations than the technical definitions by which it is understood in industry. When it appears that the intended meaning goes beyond the technical definition, "white spirit" is shown in quotation marks. 5 Amoruso et al. (2008) summarized compositional information from publications and industry sources for "full range", reduced aromatic, and low aromatic white spirit. Carrillo et al. (2014) tabulated compositional information on white spirit as it was produced in Europe between 1980 and 2011. These compilations provide information on compositional variations between the types of products from both US and European sources over the past 40 years. 6 For a more detailed explanation of grouping/category and analogous substance approaches to read across, see CEFIC (2012).
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Regulatory Toxicology and Pharmacology 92 (2018) [439] [440] [441] [442] [443] [444] [445] [446] [447] [448] [449] [450] [451] [452] [453] [454] [455] [456] [457] a According to the rules of the naming convention, the carbon number range must include 80% of the constituents, but constituents present at lower levels are not necessarily reflected in the substance name. b Category 2 was defined as C10-C12 aromatics for REACH purposes, based on the naming convention rules. However, it was re-designated as C10-C13 aromatics in the OECD HPV program. c NIC = Normal paraffins, isoparaffins, cycloparaffins (cyclics). NA -Data not available.
Regulatory Toxicology and Pharmacology 92 (2018) 439-457 summarized below the no effect level for acute CNS effects in rodents is 600 mg/m 3 and that for humans is in the range of 300-500 mg/m 3 . As summarized in McKee et al. (2015) , the C9-C11 aliphatic constituents are metabolized by ω-oxidation of the alkyl side chains leading to the formation of hydroxylated metabolites, primarily fatty alcohols and fatty acids. The fatty acids then undergo a β-oxidation process leading to the formation of metabolites that are either incorporated in the biosynthesis of fatty acids and lipids, exhaled as CO 2 , or excreted in the urine as free or conjugated metabolites. The aromatic constituents are metabolized to the corresponding alcohols that are ultimately excreted in the urine as glucuronide or sulfate conjugates. The majority of the metabolites are excreted relatively quickly, but a fraction of the absorbed hydrocarbons is retained in adipose tissue for longer periods of time.
Results of toxicological investigations in animals
As summarized by Amoruso et al. (2008) , C9-C14 aliphatic (2-25% aromatic) hydrocarbon solvents have a low order of acute toxicity with oral and dermal LD 50 values greater than 2000-5000 mg/kg, the limits in acute toxicology tests for regulatory purposes, and inhalation LC 50 values greater than saturated vapor concentrations. However, these solvents can cause chemical pneumonitis if aspirated into the lungs in a liquid state (McDermott, 1975) . The potential for skin irritation is related to experimental design. Under most conditions, hydrocarbon solvents evaporate from the skin without producing more than slight dermal irritation, but severe irritation can occur if evaporation is impeded, e.g., through the use of an occluded patch. The introduction of C9-C14 aliphatic (2-25% aromatic) hydrocarbon solvents into the eyes results in minimal ocular irritation, but exposure to high vapor concentrations can cause ocular and upper respiratory tract irritation. Studies in guinea pigs provided evidence that these solvents do not produce allergic contact dermatitis, and this was confirmed in studies with volunteers (Amoruso et al., 2008) . Gochet et al. (1984) reported that a sample containing 15% aromatic hydrocarbons was not mutagenic. Other samples of white spirit did not produce developmental effects (American Petroleum Institute, 1977; Jakobsen et al., 1986) . 7 Although there have been no formal reproductive toxicity studies of these solvents, there is evidence from studies on similar, less refined substances; orally administered jet fuel (Cooper and Mattie, 1996; Mattie and Sterner, 2011) and dermally administered hydrodesulfurized kerosene (Schreiner et al., 1998 ) that provided evidence that effects on fertility are unlikely. The jet fuel and hydrodesulfurized kerosene data also further support the conclusion that C9-C14 aliphatic (2-25% aromatic) hydrocarbon solvents are not developmental toxicants.
8
The majority of the repeated dose studies have been by inhalation as that is considered the most likely route of human exposure; however, there have also been some repeated oral administration and dermal application studies of these solvents and similar substances. The first published inhalation toxicity study (Rector et al., 1966) investigated the effects of repeated exposures to mineral spirits (13-19% aromatics) in rats, guinea pigs, rabbits, dogs and monkeys. Animals were exposed by inhalation for 90 days under continuous exposure conditions at levels ranging from 114 to 1271 mg/m 3 (21-230 ppm) and also in studies in which animals were exposed 8 h/day, 5 days/week for 30 weeks at levels ranging from 593 to 1353 mg/m 3 (108-231 ppm). There was no consistent evidence of toxicological effects in rats, rabbits, dogs or monkeys at any of the treatment levels used in these studies. However, the guinea pigs were more susceptible with mortality observed at levels of 363 mg/m 3 (66 ppm) and above. In a later study (Jenkins et al., 1971) , it was shown that the diet used for guinea pigs in the study by Rector et al. (1966) was deficient in vitamin C. Jenkins et al. (1971) showed that guinea pigs maintained on high ascorbic acid diets were less susceptible to the effects of mineral spirit (18-20% aromatics) than those on low ascorbic acid diets, suggesting that the results of the toxicological studies may have been influenced by dietary factors. Carpenter et al. (1975) reported that in inhalation toxicity studies of "Stoddard solvent", (∼15% aromatics) exposure at levels up to 1900 mg/m 3 (345 ppm) for 65 days produced no notable effects in dogs. However, in rats, exposure to 1900 mg/m 3 resulted in slight pathological changes in the kidneys. Carpenter attributed these kidney effects to an exacerbation of chronic progressive nephropathy, but in later studies they were shown to have been the consequence of an α2u-globulin-mediated process and not relevant to humans (Swenberg and Lehman-McKeeman, 1998 ; U.S. Environmental Protection Agency, 1991). The Carpenter publication was followed by several studies that focused specifically on the kidney effects (Phillips and Cockerell, 1984; Viau et al., 1984) . In the most recent published study (Carrillo et al., 2014 ) rats were exposed by inhalation for 90 days at target concentrations of 2000, 4000, and 8000 mg/m 3 (345, 690, or 1293 ppm) white spirit (19% aromatics). The highest exposure level approximated the maximally attainable vapor concentration. All of the animals survived to scheduled sacrifice. Terminal body weights of animals in the high dose group were significantly below control levels. There were some statistically significant differences in hematological and clinical values, but all were within normal physiological limits. Weights of liver, kidneys and spleen were elevated, but the only pathological findings were male rat kidney changes consistent with an α2u-globulin-mediated process. The overall no observed adverse effect level (NOAEC) was an analytically determined concentration of 4000 mg/m 3 (690 ppm). As this study investigated the highest exposure levels and identified both low effect and no effect levels, the study by Carrillo et al. (2014) was selected as the key study, and the NOAEC (4000 mg/m 3 ) was taken forward for DNEL derivation. The NOAEC from the Carrillo study is supported by results of a repeated dermal toxicity study of Stoddard solvent (American Petroleum Institute, 1989; 14% aromatics) in which the only notable effect was severe irritation at the application site. There have also been oral and inhalation toxicity studies of jet fuels JP-8 and Jet-A (Mattie and Sterner, 2011) in which the principal effects were kidney changes consistent with an α2u-globulin-mediated process, at treatment levels similar to those in the Carrillo study, and repeated dermal toxicity studies of hydrodesulfurized kerosene in which there were no systemic or neurological effects at 495 mg/kg/day, the highest dose tested (Breglia et al., 2014; Schreiner et al., 1998) .
There have not been any formal chronic toxicity/carcinogenicity studies of white spirit per se, but there was a 2 year study of "Stoddard solvent IIC (CAS registry number 64742-88-7), corresponding to a low (< 2%) aromatic hydrocarbon solvent (NTP, 2004) . Rats and mice were exposed by inhalation, 6 h/day, 5 days/week for 105 weeks. The rats were exposed at concentrations of 550, 1100 and (females only) 2200 mg/m 3 . Mice were exposed to 550, 1100 and 2200 mg/m 3 . At termination survivors were sacrificed and examined for pathological changes. The principal findings in the male rats were changes in the kidneys and an increase in adrenal gland tumors (pheochromocytomas) with the frequencies being significantly elevated in the 550 and 7 The sample tested by the API had 24% aromatics, and that used by Jakobsen et al. had 17%. 8 As noted above, JP-8, Jet-A, and hydrodesulfurized kerosene are complex petroleumderived substances, manufactured by the same processes used to produce the C9-C14 aliphatic (2-25%) aromatic hydrocarbon solvents, and also containing approximately 20% aromatic constituents, but these fuels have wider distillation ranges than the corresponding hydrocarbon solvents. Thus the toxicological data from these fuels can be used as supporting information to characterize the toxicological hazards of the corresponding hydrocarbon solvents.
9 According to Carrillo et al. (2014) the test sample used in this study was comprised of C9-C11 hydrocarbons of which 71% were aliphatics (56% n-and iso-paraffins), 25% naphthenes and 19% aromatics (primarily branched mono-aromatics).
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Regulatory Toxicology and Pharmacology 92 (2018) [439] [440] [441] [442] [443] [444] [445] [446] [447] [448] [449] [450] [451] [452] [453] [454] [455] [456] [457] 1100 mg/m 3 groups. In female mice there was an increase in hepatocellular carcinoma which was considered to have been associated with increased body weight. There was no evidence of increased tumor incidence in the female rats or male mice. The NTP concluded that there was some evidence of carcinogenicity in male rats due to the increase in adrenal gland tumors but no or equivocal evidence in female rats and mice. The relevance to humans of the adrenal gland tumors is controversial (Greim et al., 2009) , and, according to a recent compilation, Stoddard solvent/white spirit has not been classified for carcinogenic risk to humans (ATSDR, 2015) . Because of concerns that "white spirit" could cause persistent neurological effects in humans (discussed in the next section), there have been a number of studies to assess the potential for these solvents to cause neurological effects using animals. Carpenter et al. (1975) reported that rats exposed to "Stoddard solvent" (15% aromatics) for 8 h at 8200 mg/m 3 (1490 ppm) exhibited a slight loss of coordination but that no effects were observed in animals exposed to 4600 mg/m 3 (836 ppm). In a study to systematically characterize acute neurobehavioral effects, Lammers et al. (2007) reported that exposure to white spirit (∼25% aromatics) at levels of 2400 or 4800 mg/m 3 (436 or 873 ppm) for 8 h resulted in delays in time to response in a visual discrimination performance test. The no effect level was 600 mg/m 3 (109 ppm). Effects were observed when the rats were tested immediately after exposure, but no effects were observed when the animals were tested on the following day, providing evidence that these effects are acute and reversible.
In longer term studies, Kulig (1990) exposed rats to white spirit (18% aromatics) at levels of 1200, 2400, or 4800 mg/m 3 (218, 436, 873 ppm), 8 h/day, 5 days/week for 26 weeks. Psychomotor slowing was observed at all exposure levels in tests conducted immediately after exposures. However, there was no evidence of persistent motor or functional changes, and no pathological changes in nervous system tissue were observed at terminal sacrifice. A number of authors reported neurochemical changes in the brains of rats following repeated exposures (Bondy et al., 1995; Lam et al., 1992 Lam et al., , 1995 Lam et al., , 2000 Ostergaard et al., 1993; Saviolainen and Pfaffli, 1982; Steensgaard et al., 1996), 10 but no consistent and reproducible evidence of pathological changes in the central or peripheral nervous system has been documented (Nielsen et al., 2006) .
2.5. Human evidence 2.5.1. Investigations of the acute effects of C9-C14 aliphatic (2-25% aromatic) hydrocarbon solvents in humans The earliest reported investigation of these solvents in humans was a study in which volunteers were exposed for 3-5 min to various solvents and then asked for their impressions (Nelson et al., 1943) . Stoddard solvent did not produce eye, nose or throat irritation at 400 ppm (2200 mg/m 3 ), but the subjects considered that that level was too high for an 8 h work day. From similar experiments, Carpenter et al. (1975) reported that 150 ppm (825 mg/m 3 ) was minimally irritating but that 470 ppm (2585 mg/m 3 ) was unacceptable as a workplace exposure level. Carpenter et al. (1975) concluded that their data were consistent with an 8-h Threshold Limit Value (TLV ® ) of 200 ppm (1100 mg/m 3 ).
At approximately the same time, the American Conference of Governmental Industrial Hygienists (ACGIH) adopted a TLV ® of 100 ppm
(525 mg/m 3 ), based primarily on the results of the human observational studies of Nelson et al. (1943) and Carpenter et al. (1975) . Since that time there have been a number of additional studies in which volunteers have been exposed to solvents of this type at various levels for periods ranging from a few minutes to several hours Ernstgard et al., 2009a Ernstgard et al., , 2009b Gamberale et al., 1975; Hastings et al., 1982; Juran et al., 2014; Lammers et al., 2007; Pedersen and Cohr, 1984) . In general, these studies are consistent with the earlier reports from Nelson and Carpenter and provide evidence that exposure at levels below 100 ppm (525 mg/m 3 ) does not cause more than minor acute CNS effects or mild ocular and upper respiratory irritation. Cohr et al. (1984) , however, reported that acute CNS effects were evident at exposure levels at or even below 100 ppm among previously occupationally exposed individuals whereas naïve subjects were only affected at higher levels. Some of the variability across these studies is due to experimental methods which have become increasingly sensitive over the years; however, there may also be some differences due to compositional variation. The aromatic constituents are more irritating to the upper respiratory tract and produce acute CNS effects at lower levels than do the corresponding aliphatics (McKee et al., 2015) . Differences in both CNS effects and respiratory irritation were reported in acute studies that compared the effects of "full range" to low aromatic content white spirit (e.g., Ernstgard et al., 2009a Ernstgard et al., , 2009b Juran et al., 2014) . However, the extent to which different responses due to smaller differences in composition could be discerned is unknown. An overall conclusion from the human evidence is that the no effect concentration for both acute CNS effects and upper respiratory tract irritation is in the range of 300-500 mg/m 3 . 2.5.2. Investigations of the potential for C9-C14 aliphatic (2-25% aromatic) hydrocarbon solvents to cause persistent neurological effects in humans
There are reports that long term exposure to white spirit can cause persistent neurological effects in humans (e.g., IPCS, 1996) . The relevant data come from studies of workers exposed to "white spirit" while working as construction painters between approximately 1960 when white spirit replaced solvents such as linseed oil in paint formulation and 1980 when the industry converted to water-based paint formulations. It should be noted that other types of paints, particularly those used in spray painting applications were formulated with other solvents.
11 Thus the results of studies of painters exposed in painting occupations other than construction painting may be relevant to broader questions relating to solvent exposure and chronic neurological effects but are not directly relevant to white spirit specifically. There were 3 early reports that documented neurobehavioral studies of construction painters (Hane et al., 1977; Lindstrom and Wickstrom, 1983; Seppalainen and Lindstrom, 1982) , and two later, retrospective studies that focused on painters including those who had worked in the construction painting industry while white spirit was being used in paint formulation (Lundberg et al., 1995; Mikkelsen et al., 1988) . The principal findings that were associated with exposure of painters were small but statistically significant decrements in some psychometric tests, but there was no association between working as a painter and the development of more severe psychiatric symptoms. Most of the authors attributed these psychometric effects to exposure to solvents during painting, but Mikkelsen et al. (1988) specifically identified "white spirit" as the causative agent as it had been the solvent used in greatest volume in paints formulated for use in the construction industry between 1960 and 1980. There are, however, at least two alternative explanations that do not appear to have been critically examined. One is that the effects were due to over-exposure to more volatile solvents through the use of enamel paints as documented by Riala 10 The majority of the authors tested white spirit with aromatic contents ranging from 18 to 20%, but Bondy reported that the sample tested in his studies contained 14-21% aromatics, and Saviolainen and Pfaffli tested a sample with 12% aromatics.
11 Construction painting was primarily by brush or roller, so paint solvents needed to be of lower volatility in order for the paint to be applied. White spirit/Stoddard solvent was well -suited for this application. For spray painting applications which usually involved the application of paint to metal surfaces required more volatile solvents with greater solvency power. The types of solvents used in these applications included volatile aromatics such as toluene, ketone, alcohol and ester solvents and, to a limited extent, relatively volatile aliphatic solvents containing primarily C7-C9 constituents (Grandou and Pastour, 1966) .
Regulatory Toxicology and Pharmacology 92 (2018) 439-457 et al. (1984) . A second is that the neurobehavioral effects were due to more intense exposures to solvents used in spray painting as is evident in the exposure profiles documented in Mikkelsen et al. (1988) . Whether or not small decrements in psychometric tests are clinically relevant is controversial (e.g., Fairhurst, 2003; Gamble, 2000; LeesHawley and Williams, 1997) but beyond the scope of this paper. For purposes of this discussion, it should be noted that in the most recent occupational study of construction painters, Lundberg et al. (1995) reported that there were no statistically significant decrements in performance in the low exposure group -in fact, both Lundberg and Mikkelsen reported that the performance of painters in the low exposure groups was superior to that of the corresponding control groups. Using the Lundberg data, the European Scientific Committee for Occupational Exposure Limits (SCOEL) estimated that the upper limit of the low exposure group was equivalent to an average exposure of approximately 540 mg/m 3 (SCOEL, 2007). Thus, whether or not white spirit per se can cause neurological effects, the empirical evidence indicates that both acute and persistent effects are unlikely if the ACGIH TLV ® of 525 mg/m 3 (100 ppm) is observed. This information provides a useful benchmark in the context of DNEL values which were derived from animal data as discussed in the next section.
DNEL calculations
As stated in the introduction, REACH registration requires calculation of DNELs for workers and the general population for the three principal routes of exposure; inhalation, oral and dermal. However, as white spirit is not intended for ingestion, non-accidental oral exposures are minimal and oral DNELs were not calculated for this example.
As the principal effects of white spirit are irritation of the eyes and respiratory tract and acute CNS depression, it does not fall easily into the standard methods of DNEL derivation and judgment is required. The examples shown below were based on guidance available in 2010 when the substances were registered, and it seemed reasonable to continue to use these values for illustrative purposes. Changes in regulatory guidance since that time would likely result in different values being calculated but the overall process would remain the same.
The above having been said, the examples provided illustrate the calculation of DNELs from the results of toxicology studies in rats. As shown below, No Observed Adverse Effect Levels (NOAELs) from studies in rats are converted to human equivalents. These values are then adjusted through the use of assessment factors 12 as shown in Tables   3-7 . Default values are given in the REACH guidance; however, these values can be adjusted to incorporate substance-specific information.
Because of the large amount of both human and animal data that is available, some alternative assessment factors recommended by the European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC, 2003) were used. More specifically, the REACH technical guidance recommended that consideration be given to 6 possible adjustment factors: route to route extrapolation; inter-species; intra-species; exposure duration; dose-response; and quality of the database. Of these, no adjustments were considered necessary in the present study for route to route extrapolation, as it was unnecessary; dose-response for which high quality data were available; and quality of database, since most of the endpoints were addressed by several studies, and additional supporting data were also available. For interspecies comparisons, the REACH guidance recommends a factor of 10 (4 for pharmacokinetic differences and 2.5 for pharmacodynamics differences). ECETOC notes that these allometric scaling factors are already incorporated in the calculations by which the no effect levels in animals are converted to their human equivalents, as was done for the present example, and, therefore, no additional adjustment factors were applied.
For intra-species adjustment, the REACH guidance recommends factors of 5 for workers and 10 for the general population. In contrast, ECETOC (2003) estimated that the upper 95th percentile of the intraspecies differences was approximately 4. Accordingly, they recommended that an adjustment factor of 5 would be appropriate for the general population, and 3 for a worker population, which would be more homogeneous. For the present study, the values of 3 and 5 were used for the calculations, noting that the principal effects associated with white spirit exposure in both humans and animals are acute CNS effects and upper respiratory irritation. As explained previously, the PBPK model estimate is that the differences in CNS effects between rats and humans would be within approximately a factor of 2, and this is consistent with the experimental evidence.
For subchronic to chronic extrapolation, both ECHA and ECETOC recommended a factor of 2. This also seemed to be a reasonable value, given the other available information. More specifically, in the key toxicological studies, the effects were reduced body weights and increased spleen weights. Although there are no long term studies of white spirit, no splenic changes were noted in the chronic study of Stoddard solvent Type IIC, which is equivalent to the aliphatic fraction of white spirit, and there were also no notable effects on body weight gain. Similarly, there were no effects on the spleen and no long term effects on body weight gain in a 12 month study of high flash aromatic naphtha, a substance similar to the aromatic fraction of white spirit (Clark et al., 1989) . In humans, the only non-acute effects that have been associated with white spirit exposure are chronic neurological deficits. Whether or not these reported changes were due to white spirit exposure, the evidence indicates that these effects do not occur when exposures are limited to those set on the basis of the acute effects. Thus, as there is no evidence that the effects observed in a 90 day inhalation toxicity test are progressive or related to pathologic changes in humans, the adjustment factors used seemed reasonable.
Long-term DNEL for workers, inhalation route
As indicated above, the key study identified for use in calculating the long-term worker DNEL for inhalation exposure was a 90-day 12 "Assessment factor" is the term used by ECHA to refer to the factors applied to results of animal studies to calculate levels of human exposure that are assumed to be below levels of concern. These are analogous to "adjustment factors", "uncertainty factors", or "safety factors" used by other organizations.
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Regulatory Toxicology and Pharmacology 92 (2018) [439] [440] [441] [442] [443] [444] [445] [446] [447] [448] [449] [450] [451] [452] [453] [454] [455] [456] [457] inhalation toxicity study in which rats were exposed at levels of approximately 2000, 4000, and 8000 mg/m 3 , 6 h/day, 5 days/week, for 13 weeks to a regular white spirit (hydrocarbons, C9-C12 aliphatics, 2-25% aromatics) (Carrillo et al., 2014) . The principal findings in the high exposure group were lower body weights and increased spleen weights (without pathological changes); the intermediate exposure level, 4000 mg/m 3 by analytical determination, was selected as the no observed adverse effect concentration (NOAEC). Following the REACH guidance(European Commission, 2006), a NOAEC in rats is converted to a human equivalent NOAEC by adjusting for the length of the exposure period and accounting for metabolic differences between rats and humans. More specifically: By reference to the human and animal information summarized above, a DNEL of 335 mg/m 3 seems reasonable as a benchmark to evaluate occupational control measures.
Long-term DNEL for workers, dermal route
Although there are no repeated dose dermal studies of C9-C14 aliphatic (2-25% aromatics) hydrocarbon solvents, there are two dermal application studies of hydrodesulfurized kerosene which is effectively the feedstock from which category 3 solvents are produced (Breglia et al., 2014; Schreiner et al., 1998) , and, therefore, provide a worst case assessment. As described previously, these studies assessed the potential for systemic, neurological, developmental and reproductive effects. The test material was applied in daily doses of 495 mg/kg/day, a dose level chosen to avoid severe dermal effects from repeated administration. There were no notable effects in either study aside from local changes at the application site. Using the adjustment factors shown in Table 4 : = = = DNEL NOAEL /Assessment factor 495 mg/kg/24 21 mg/kg/day rat Note that a species-specific absorption factor was not used in the rat to human extrapolation because human skin is considered less permeable than the skin of other species (Barber et al., 1992; Bronaugh et al., 1982; Bronaugh and Maibach, 1987) . Thus, the use of the rat data to estimate absorption introduces a conservative element into the calculation.
It should also be noted that the dose on which the DNEL is based is the total absorbed (or systemic) dose, assuming 100% absorption through the skin. As described previously, dermally applied constituents of C9-C14 aliphatic (2-25% aromatic) hydrocarbon solvents are not well absorbed. Percutaneous absorption data for hydrocarbon solvent constituents were reviewed. The amount of solvent absorbed from an external dose was estimated to be 1 percent (Riviere et al., 1999) . According to the REACH guidance, an adjustment factor should be applied to the DNEL to account for the differences between applied and absorbed material. However, it seemed more transparent to use the absorption factor in the risk assessment determination rather than as an adjustment to the DNEL. Thus, the DNEL carried forward for risk assessment was 21 mg/kg/day, and a 1% absorption factor was used to adjust the external exposure estimates. Conventional controls including gloves were later recommended to further reduce the potential for risks associated with dermal exposure.
Long-term DNEL for the general population, inhalation route
For the general population the underlying assumptions were the same as those used in the calculation for workers, but the assessment factors (Table 5) were larger to account for the possibility of continuous exposure.
The inhalation DNEL for the general population was based on the same inhalation toxicity as used for workers, i.e., a NOAEC of 4000 mg/m 3 . Regulatory Toxicology and Pharmacology 92 (2018) 3.4. Long-term DNEL for general population, dermal route
As noted above, the development of the dermal DNELs is based on two dermal application studies of hydrodesulfurized kerosene which is effectively the feedstock from which C9-C14 aliphatic solvents are produced and, therefore, the studies of Breglia et al. (2014) and Schreiner et al. (1998) provide a "worse case" basis for the assessment of the potential hazards of white spirit. The Breglia and Schreiner studies assessed the potential for systemic, neurological, developmental and reproductive effects, and, as there were no effects in either study, the highest dose level tested, 495 mg/kg/day, was selected as NOAEL in both.
Using 495 mg/kg as the point of departure and assuming percutaneous absorption to be similar in both species: = = NOAEL(human) NOAEL (rat) 495 mg/kg/day Then applying the assessment factors shown in Table 6 
Evaluation of risks to downstream users
Under the REACH regulation, if a substance has adverse effects, the manufacturer or importer must assess the risk to the consumers, workers and/or the environment under typical use conditions and relevant estimates of exposure. The end result is a Chemical Safety Assessment (CSA) for each registered use for each substance sold in quantities of ten tons or more per year. The outcome of the chemical safety assessment is captured in a summary document called an Exposure Scenario (ES) which forms part of the registration dossier. Exposure scenarios describe the conditions under which each use can be performed safely and includes any additional control measures needed to avoid over-exposure when compared against the safe use limit value (DNEL for human health) derived for the substance (Marquart et al., 2007) .
The registration and associated ESs are specific to substances. In the European Union (EU), persons handling any hazardous substance now receive Safety Data Sheets (SDS) containing ESs with the safe handling recommendations for each registered use. For formulated products containing one or more hazardous substances, formulators must consider the safe use information communicated via the relevant ES for each hazardous substance and in turn, ensure that relevant safe use information is included in the main sections of the SDS or appended to the SDS for the formulated product.
The exposure assessment can be accomplished using exposure estimation methods or by the use of measured data. Exposure estimation methods are used in most cases. Measured data, although preferred, can sometimes be difficult for manufacturers to obtain for specific substance uses. Additionally, sharing of exposure data between manufacturers and/or between manufacturers and downstream users can also be difficult because of company proprietary and confidential business issues.
Alternative data sources include studies reported in the published literature. Exposure studies on Stoddard solvent date back to the 1960s when it was commonly used in dry cleaning and some paint formulations (ACGIH, 2015; Galea et al., 2015; Lundberg et al., 1995; Oberg, 1968) . In dry cleaning plants, ambient air concentrations of 65 ppm (Oberg, 1968) . Riala et al. (1984) examined airborne concentrations and ventilation conditions associated with solvent use during maintenance painting and varnishing with alkyd paint. At the time that work was conducted, water-based paints had largely replaced oil-based paints. In a questionnaire of 231 painters, Riala et al. (1984) found two thirds were using water-based paint the majority of time. About half of painters surveyed also reported that when using paints containing solvents they nearly always utilized respiratory protection. In these studies, short term 15 minute air samples and samples up to 3 hours duration were collected and averaged together. The air concentrations for white spirit during the roller and brush painting activities in different sized rooms without ventilation averaged 194 ppm (n = 43) (1125 mg/m 3 ) for the short task durations sampled. When mechanical or natural draft ventilation was present ambient air concentrations during tasks averaged 38 ppm (n = 26) (220 mg/m 3 ). Riala et al. (1984) also noted that spray painting was uncommon for the construction and maintenance sites they studied. Of the few spray painting tasks sampled, they found airborne concentrations during short sampling periods, without ventilation to be 235 ppm (n = 3) (1363 mg/m 3 ). Average lower concentrations of 39 ppm (n = 5) (226 mg/m 3 ) were measured when mechanical ventilation was present. These data reflect concentrations for the task duration, not full shift 8 h time weighted average (TWA) results. In questionnaire responses, painters indicated one half or more of their work time involved preliminary preparations, plastering or wall papering. When Riala et al. (1984) aggregated the non-exposure period and task-exposed periods, they found the overall full shift time weighted average exposure was 40 ppm (232 mg/m 3 ). The study highlights the need to appropriately 13 When exposure levels were given in parts per million (ppm), they were converted to mg/m 3 using the relationship 1 ppm = 5.8 mg/m 3 (SCOEL, 2007).
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Regulatory Toxicology and Pharmacology 92 (2018) [439] [440] [441] [442] [443] [444] [445] [446] [447] [448] [449] [450] [451] [452] [453] [454] [455] [456] [457] factor both non-exposure work time and task-exposure time in determining the overall full shift TWA exposure result. When comparing exposure to the DNEL (which is derived on the assumption of an 8 hour daily exposure period), the estimate similarly should be based on an 8 hour TWA. The Riala et al. (1984) study also demonstrated the importance of exposure control measures when handling solvents in certain use conditions and shows that mechanical or natural draft ventilation via windows and doors can result in exposure reductions of as much as 80-83%.
In the printing industry Stoddard solvent or white spirit was often used as a cleaning agent in the late seventies. Exposure measurements of press operators in printing offices in Norway, taken during cleaning activities between 1978 and 1979, found airborne concentrations ranging from 50 to 100 ppm (290-580 mg/m 3 ). The recommended occupational exposure limit at the time was 100 ppm. Over the next several years the use of white spirit in the printing industry diminished as it was replaced by other solvents (Svendsen and Rognas, 2000) .
More recent air measurement data for solvents and other end use applications were found in a U.S. database called the Integrated Management Information System (IMIS). Data in IMIS comes from surveys of various industrial worksites recorded by inspectors for the US Occupational Safety and Health Administration (OSHA). It should be noted that data in IMIS may be inherently biased as it represents samples collected during regulatory inspections to assess worst case conditions triggered by complaints or concerns. Sarazin et al. (2016) analyzed personal exposure measurements recorded in the IMIS database from 1979 to 2011. The dataset for Stoddard solvent alone contained over three thousand personal exposure measurements. Within the dataset for Stoddard solvent, four percent of the measurements exceeded the ACGIH TLV ® . Although the publicly available IMIS data provides exposure levels for many substances present in an industry or occupation, contextual information on tasks sampled and exposure controls present is limited, which makes it difficult to know the conditions that contributed to elevated exposure.
When measurement data for specific activities is not available, exposure estimation models are often utilized to support health risk assessment. For occupational risk assessment, several exposure estimation models were developed to assist with REACH implementation. These are highlighted in guidance from the European Chemicals Agency (ECHA, 2012a (ECHA, , 2012b 2012c) .
The exposure estimation tool used most commonly for occupational risk assessment, including those for white spirit, was the ECETOC Targeted Risk Assessment (TRA) model (ECETOC, 2004; . The ECETOC TRA provides both inhalation and dermal exposure predictions. Separate tools were applied to assess consumer use in order to determine whether or not the recommended exposure limits were being exceeded. As an example, the solvent industry developed the European Solvents Industry Group (ESIG) Generic Exposure Scenario (GES) Risk and Exposure Tool (EGRET) for estimating exposure and risk characterization of solvent uses associated with consumer products. More information on this consumer risk assessment tool can be found elsewhere (Zaleski et al., 2013) .
For white spirit the occupational exposure estimates predicted by ECETOC TRA for inhalation ranged from 0.06 mg/m 3 to 646 mg/m 3 depending on use applications. As an example, the highest exposures estimated by the TRA were associated with spraying of coating or cleaning agents in professional work settings. For the dermal exposure route, ECETOC TRA predictions ranged from 0.34 mg/kg/day to 141.43 mg/kg/day. The higher dermal exposure value being associated with manual hand mixing applications. Lower exposure estimates are related to manufacturing conditions with closed systems. A requirement imposed by REACH is that a chemical safety assessment encompass all registered uses and exposure conditions. This presented a number of challenges to the regulated community. Use information and exposure conditions had to be collected by manufacturers and importers. In order to manage these requirements, the European solvents manufacturing trade association, the European Solvents Industry Group (ESIG), joined with downstream solvent users to form a coalition, the European Solvents Volatile Organic Compound (ESVOC) group, to identify solvent uses. This group also identified the common tasks, typical operational conditions, and the most commonly recommended risk management measures that could be applied. For white spirit alone there were approximately 25 registered uses involving industrial, professional, and consumer applications. Because each of the solvent uses and associated tasks required a chemical safety assessment, there were hundreds of conditions that needed to be evaluated. To effectively process the many exposure evaluations for the industry, a generic risk assessment system was developed, termed the Generic Exposure Scenario (GES) process (CEFIC, 2009; Money et al., 2011) .
The GES process embraced control banding approaches. Control banding involves assigning chemicals to volatility bands on the basis of health hazard potency and exposure potential. The bands were combined to create a matrix. Exposure control strategies were then defined for each section describing predetermined risk management options. Fig. 1 illustrates the control banding technique and how it was applied for risk assessment.
For solvents, vapor pressure is a key factor influencing the inhalation exposure risk. High, moderate and low volatility ranges for each GES were adopted from those previously established by the ECETOC TRA (ECETOC, 2009a) . DNEL bands were categorized as high, medium, or low severity by the ESVOC group. Boundary conditions which centered on molecular weight and permeation coefficient were also defined for dermal risk assessments for the various substances.
The CSA process under REACH compares an exposure (actual or estimated) to a toxicological DNEL. When the exposure value is greater than the DNEL a risk control action must be implemented to lower the exposure. When exposure is less than the relevant DNEL, health risks are considered to be controlled.
A GES was developed for each solvent use. Embedded in each GES were common tasks called Contributing Scenarios (CSs) associated with the use. As an example the GES for substance "Use in Coatings" contains CSs for roller brushing, spraying, material transfer, and end of day cleaning maintenance activities. The ESVOC working groups Fig. 1 . The process (control banding) by which the need for additional risk management measures (RMM) is identified. Measures that most efficiently reduce the risk to acceptable levels are defined with consideration to practicality of controls.
Regulatory Toxicology and Pharmacology 92 (2018) 439-457 determined the applicable CS tasks. As many as 23 contributing scenario tasks might be contained in one GES. This was the case for use in Rubber Production and Processing. Overall, for 25 uses, there could be 300 or more contributing scenario tasks assessed for occupational exposure risk determination. Exposure values associated with each contributing scenario task were obtained by linkage to a REACH descriptor termed Process Category (PROC) (ECHA, 2015) . The PROCs are standardized codes used in REACH and are specific to tasks in occupational settings. Exposure estimations for each PROC are provided by the ECETOC TRA Tool. Excel ® was used to help manage chemical safety assessment workflows. Spreadsheet-based tools were created with embedded formulas to look up PROCs and to retrieve the TRA predicted exposure estimate for each PROC assigned to a CS. The basic inputs required to run the tools were substance vapor pressure, molecular weight, and inhalation and dermal DNELs. Substance concentration was assumed to be 100 percent unless specifically indicated otherwise and supported by typical use conditions identified during ESIG ESVOC GES dialogue.
In 2010 there were 21 PROCs applicable to solvent uses in the REACH use descriptor system when solvents were initially registered. Exposure estimates given for each PROC were compared to the relevant DNELs. The integrated comparison of exposure to DNEL characterizes risk as a simple ratio. For example, the TRA estimated inhalation exposure for white spirit during roller application or brushing (PROC 10) was 152 mg/m.
3 . This exposure value compared to the DNEL (335 mg/ m 3 ) resulted in an inhalation Risk Characterization Ratio (RCR) of 0.45. As this RCR is below 1, the use of white spirit during roller or brushing applications can be considered controlled and additional measures to reduce inhalation exposure are not necessary. This assumes recommended good occupational hygiene practices are followed and appropriate precautions are observed to prevent a flammable condition hazard.
When inhalation and dermal RCRs were combined for a task and the resultant RCR value was > 1, appropriate exposure reducing controls (e.g. mechanical ventilation, gloves, etc.) were added. The CSA was repeated until an RCR below 1 was achieved. ECETOC later released enhancements to the model as TRA version 3, prompting the required GESs and associated controls to be updated. ESVOC identified several Risk Management Measures (RMMs) commonly associated with solvent use. As one example, for indoor spray activities, the RMMs advised included to "Carry out in a vented booth", "Limit the substance content in the product to 25%" and "Wear suitable gloves tested to EN374". Each affording exposure reductions to inhalation or dermal estimates ranging from forty to eighty percent. Additionally, specialized RMM control measures such as drum pumps that were not inherently part of the ECETOC TRA control options, but commonly used, were also advised in certain scenarios. Exposure control could also be achieved through use of respiratory protective equipment (RPE) which reduces the estimated exposures by ninety percent. RPE was recommended when needed for unique work activities that could not be accomplished safely by any other means of controlling exposure. Justifications for exposure reductions associated with the above control measures were described in various publications. Follow up simulations were later carried out to confirm control effectiveness when direct measurement data was not available (Bluemlein et al., 2017; Fransman et al., 2008; CONCAWE, 2012; ECHA, 2012a; , 2012c ECETOC, 2009a ECETOC, , 2012 .
Each GES developed followed the CSA process described above. One Excel workbook represented one GES. Each included the complete set of appropriate CS tasks and PROCs and was programmed to accommodate the various assessment combinations. Each DNEL and volatility band combination that was assessed represented a hypothetical GES substance having similar physicochemical characteristics and hazard properties. Each GES workbook housed exposure assessments for three exposure bands and two DNELs covering inhalation and dermal routes of exposure. The GES tools were then shared with industry registrants to facilitate assessment of hundreds of similar substances producing consistent advice in an efficient timely manner. In total ESVOC provided 22 GES templates to cover 80% or more of the identified solvent uses.
The final feature of a GES template was the ability to generate the ESs in a narrative format. Each ES must be included in the respective Chemical Safety Report (CSR) and annexed to the SDS for each substance. The SDS ES Annex serves to communicate to users the measures required to control exposure. The complete, formatted ES was created through Excel scripts embedded within each GES workbook. Standard phrases and codes used to build the narrative were aggregated electronically to generate the ESs and any specified RMMs (CEFIC, 2012) . The standard coded phrases were translated into local languages, which enabled consistent onward communication of the ES information to downstream users (DUs). Fig. 2 shows an example of an ES for Coating Use by professional workers.
Discussion
The health risks associated with normal uses of white spirit were evaluated for registration as required under REACH. The variety of applications registered for white spirit are shown in Table 7 . The relatively large number of occupational work activities (Table 8a) were assessed utilizing a control banding approach and GES templates, which incorporated the ECETOC TRA model exposure predictions. While measured data may be viewed as optimal, it was not practical to acquire sufficient sampling data covering all chemical use conditions throughout the supply chain. As an example, there is a lack of both measured skin exposure data for white spirit as well as standardized methods to conduct these measurements. Exposure models provide a practical means of exposure estimation for health risk assessments. ECHA guidance documents on occupational exposure assessment identified the TRA as an acceptable Tier I screening model for REACH registration. Tier I models are designed to be simple to apply, require few input parameters, and are intended to provide conservative estimations of exposure for a first assessment. The inhalation estimates modeled by ECETOC TRA provide full shift 8-hour time weighted average exposure values. For the most part the air measurement data cited in the literature for white spirit appear to be consistent with TRA estimates ranging 0.06 mg/m 3 to 646 mg/m 3 for the inhalation route over various use applications. However, Riala et al. (1984) found air levels associated with spray, roller and brush painting activities could reach 1034 mg/m 3 (197 ppm) when tasks were performed in poorly ventilated rooms. Rooms with natural or mechanical ventilation measured 200 mg/m 3 (38 ppm). When comparing to the toxicological DNEL it is important to use the full shift 8 hour TWA exposure estimate. When actual exposures during painting time were averaged with non-exposed work time, Riala et al. (1984) found the total daily mean 8 hour TWA breathing zone concentration was 210 mg/m 3 (40 ppm).
Risk characterization ratios derived for each use of white spirit can be arranged into general categories. For closed processes, Inhalation RCRs observed were < 0.1, increasing to ∼0.25 for tasks when limited exposures are present, such as laboratory activities as an example. Inhalation RCRs > 0.5 were seen for process activities at elevated temperatures. For open processes, the RCRs were ∼0.25, increasing to > 0.5 for vessel transfer activities at non-dedicated facilities entailing fewer controls. Processes associated with higher RCRs involved activities with greater energy conditions and vapor generation such as mixing, blending, spraying, dipping, rolling, brushing, cleaning, and use in lubricant/grease formulations for rotating equipment. The highest estimated RCR values for skin exposure were also associated with uses involving high energy conditions such as spraying or activities involving direct hand contact. RCRs equal to or greater than 1 (the regulatory value for risk reduction) required control measures be included and the chemical safety assessment be refined to assure the RCR was < 1. Table 9 shows before and after RCR values for the chemical 
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Results within ten percent of the RCR threshold (i.e. 0.9) prompted consideration for refinements. If the estimated RCR was > 1, based on a Tier I model and typical exposure controls, then more complex, higher tier models or measurement data could be applied. Overall, the majority of RCRs for the most common industrial applications ranged from approximately 0.3 to 0.8. Although RCRs were ultimately all below 1, exposure control measures were required in certain cases to accomplish this. Standard exposure controls or RMMs described and offered by ECETOC TRA were normally used to refine the CSA. As an example, enhanced ventilation was advised for certain activities to limit exposure and to avoid flammability risks. The TRA exposure control options (e.g., Fig. 1 ), however, do not reflect the entire range of possible control techniques available in occupational settings.
ESIG sought to identify other exposure controls conventionally 2, 3, 4, 5, 8a, 8b, 9,14, 15 4 Use in coatings 1, 2, 3, 4, 5, 7, 8a, 8b, 9, 10, 14, 15 5 Use as a component of cleaning products 1, 2, 3, 4, 7, 8a, 8b, 10, 13 6 Use as a lubricant 1, 2, 3, 4, 7, 8a, 8b, 9, 10, 13, 17, 18 7 Use as a metal working fluid/rolling oil 1, 2, 3, 4, 5, 7, 8a, 8b, 9, 10, 13, 17 8 Use in Agrochemicals 1, 2, 4, 8a, 8b, 11, 13 9
Use as a fuel 1, 2, 3, 8a, 8b, 16 10 Functional fluids 1, 2, 3, 4, 8a, 8b, 9 11
Use in Road and Construction Applications 8a, 8b, 10, 11, 13 12
Use in laboratories 15 13
Rubber production and processing 1, 2, 3, 4, 5, 6, 7, 8a, 8b, 9, 13, 14, 15, 21 14 Polymer processing 1, 2, 3, 4, 5, 6, 8a, 8b, 9, 13, 14 Use in batch and other process (synthesis) where opportunities for exposure arise PROC 5
Mixing or blending in batch processes for formulation of preparations and articles (multistage and/or significant contact) PROC 6
Calendaring operations PROC 7
Industrial spraying PROC 8a
Transfer of substance or preparation (charging/discharging) from/to vessels/large containers at non-dedicated facilities PROC 8b
Transfer of substance or preparation (charging/discharging) from/to vessels/large containers at dedicated facilities PROC 9
Transfer of substance or preparation into small containers (dedicated filling line, including weighing) PROC 10
Roller application or brushing PROC 11
Non-industrial spraying PROC 12
Use of blow agents for foam production PROC 13
Treatment of articles by dipping or pouring PROC 14
Production of preparations or articles by tableting, compression, extrusion, pelletizing PROC 15
Use as a laboratory reagent PROC 16
Use of material as fuel source, limited exposure to unburned product to be expected PROC 17
Lubrication at high energy conditions and in partly open process PROC 18
Greasing at high energy conditions PROC 19
Hand mixing with intimate contact and only PPE available PROC 20
Heat and pressure transfer fluids (closed systems) in dispersive use PROC 21
Low energy manipulation of substances bound in materials and/or articles Regulatory Toxicology and Pharmacology 92 (2018) 439-457 Table 9 Chemical safety assessment risk characterization-use in coating professional. Contributing Scenarios used. Experienced occupational health professionals evaluated the available information and applied expert judgment to establish appropriate efficiencies for the additional control measures. These were later published (CONCAWE, 2012) . These controls included various levels of containment in combination with ventilation, use of drum pumps for solvent transfer and draining and flushing procedures to prepare equipment for cleaning and maintenance operations. The European Chemistry Industry Council (CEFIC) also sponsored experimental studies to assess control efficiencies and to obtain empirical data on the effectiveness of the recommendations (Bluemlein et al., 2017) . Prior to REACH, overall solvent exposure levels had been reported as generally decreasing over time. Factors such as chemical substitution, automation, ventilation system enhancements, and overall improved personal handling practices have been suggested as reasons for exposure reduction trends (Caldwell et al., 2000; Galea et al., 2015; Svendsen and Rognas, 2000 ). As the TLV ® has been in effect for approximately 40 years, it is not surprising that the assessment process did not identify any uses that could not be controlled through common exposure reduction measures. This paper describes the risk assessment of white spirit and the process used for communication of required risk mitigation measures to downstream users. The responsibility to apply the advice to manage the exposure risks in their facilities rests with the user. Although not extensively discussed in this paper is the REACH requirement to also assess consumer risks. Consumers are also exposed through product use and have more limited options to control exposures. This is offset by the fact that consumers are typically exposed less often and for shorter periods than those in the industrial sector. Consumers receive product hazard and safe use information via product labels however, consumers commonly do not have access to safety data sheets and have less detailed knowledge of chemical hazards or control measures compared to industrial users. Accordingly, separate toxicological DNELs and approaches are used to assess consumer exposure and safe use of consumer products. A tool known as the European Solvents Industry Group Generic Exposure Scenario Risk and Exposure Tool (EGRET) was developed by the solvent industry for estimating exposure and risk characterization of solvent use associated with consumer products (Zaleski et al., 2013) .
Workplace activities in practice may involve multiple types of hydrocarbon solvents, including white spirit. The assessment of "mixed exposures" is beyond the scope of this paper but it is important to highlight the existence of tools available to address this issue. A series of papers have been published explaining how users could manage hazards of multiple exposures using occupational exposure limits to minimize workplace exposures when different hydrocarbon solvents are being used. We recommend the use of a reciprocal calculation procedure expressed as (exposure A /OEL A ) + (Exposure B /OEL B ) … = (1/ OEL for mixed solvent exposure). An explanation, recommended OELs and examples can be found in McKee et al. (2005 McKee et al. ( , 2015 McKee et al. ( , 2017 . Note, however, that the recommendations apply to complex hydrocarbon solvents and mixtures thereof.
Conclusions
The objective of this paper was to describe the chemical safety assessment process for the registration of white spirit under REACH. The usual starting point for health risk evaluation is a toxicological hazard assessment to identify any potential adverse health outcomes. As shown in this paper, white spirit is part of a category of solvents with comprehensive toxicological information. White spirit and similar UVCBs can be grouped together based on common properties and toxicity profiles. For this group of substances, the constituents have similar physical/chemical and toxicological properties, which allows the hazards to be characterized on a generic basis. In this way, the potential risks from exposure to these substances can be evaluated in the same manner as those for single constituent substances. Category groups permit common hazard profiles to be shared and distinct compositional information to be defined. The use of solvent category groups helped to reduce the apparent complexity for evaluating and regulating substance risks.
Under REACH, both hazard characterization and exposure contribute to the outcome of the quantitative risk assessment process. The scope of an exposure assessment depends on anticipated conditions of use and routes of exposure. Exposure assessment for hydrocarbon solvent substances, like white spirit are difficult because of their broad applications. Worker exposure is determined by many factors including inherent properties of the substance, conditions of use, level of containment, engineering controls present, task duration, frequency and scale of use. All of which can create potential risks which require evaluation. The focus for white spirit was primarily on the inhalation exposure route as this is considered to be the most likely route of human exposure in most circumstances, although assessments of risks from exposure by other routes were also assessed. Exposures associated with white spirit uses were estimated using the ECETOC TRA model, which were then compared to DNEL values derived from the toxicological hazard assessment. Calculated risk characterization ratios (RCRs) < 1, meant the substance could be safely used without additional risk mitigation measures. When an RCR > 1 was found, then additional risk mitigation measures were advised. The most common practical controls which could be effectively applied in various market sectors were advised first, such as use of enhanced mechanical ventilation. The GES process described in this paper helped overcome the apparent assessment challenges presented at the time of registration. The GES logic step process optimized available resources, involved appropriate manufacturing and downstream stakeholders and provided a banding approach which produced consistent risk control advice. This enabled sufficient evaluation of multiple end points, addressed classification requirements and permitted completion of the risk assessments in a timely manner.
This paper provides an example in which the evaluation of a complex substance with multiple uses was implemented using a grouping approach for both toxicity and exposure scenarios.
